Top Emerging Applications Driving Revenue In Biosimulation Market 2019
The biosimulation market is expected to reach USD 2.88 Billion by 2022 from USD 1.20 Billion in 2016 growing at a CAGR of 15.9%
(firmenpresse) - According to a new market research report "Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical Trials, PKPD, ADME), Delivery (Subscription, Ownership), End User (Biotech, Pharma Companies, CROs, Regulatory) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%.
The growth of this market is majorly driven by factors such as the increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets.
Browse 187 market data Tables and 28 Figures spread through 180 Pages and in-depth TOC on "Biosimulation Market"
Download an Illustrative overview of the report:
https://www.marketsandmarkets.com/pdfdownload.asp?id=838
Biosimulation software expected to dominate the market in 2017.
Based on product and service, the Biosimulation Market is segmented into software and services. In 2017, the biosimulation software segment is expected to account for the largest share of the biosimulation market. The high growth of this segment is attributed to the growing adoption of biosimulation software by pharmaceutical and research organizations and the increasing R&D investment for pharmaceutical research.
Based on end user, the pharmaceutical and biotechnology companies segment is projected to grow at the highest CAGR during the forecast period.
Based on end user, the Biosimulation Market is segmented into research institutes, pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, and other end users (consulting firms, defense research and development organizations, nutraceutical companies, and food and agricultural companies). The pharmaceutical and biotechnology companies segment is expected to register the highest CAGR during the forecast period. Increased R&D budgets of pharmaceutical and biotechnology companies and increasing adoption of inorganic growth strategies by different biosimulation service providers are likely to boost the adoption of biosimulation solutions in the pharmaceuticals and biotechnology industry.
North America to dominate the biosimulation market
In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as growth in the biotechnology and pharmaceutical industry, a large number of ongoing drug development processes, increased use of personalized medicine, and increasing R&D expenditure by pharmaceutical and biotechnology companies.
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=838
The Biosimulation Market is highly competitive with the presence of several small and big players. Some of the players in the Biosimulation Market include Certara (US), Simulation Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
biosimulation-market-2019
biosimulation-market-latest-trends
biosimulation-market-business
biosimulation-market-growth
biosimulation-market-size
biosimulation-market-share
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 25.04.2019 - 09:09 Uhr
Sprache: Deutsch
News-ID 1716988
Anzahl Zeichen: 3728
Kontakt-Informationen:
Ansprechpartner: Shelly Singh
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Unternehmensnachfolge
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 25.04.2019
Diese Pressemitteilung wurde bisher 1529 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Top Emerging Applications Driving Revenue In Biosimulation Market 2019"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
In-Vitro Diagnostics Quality Control Market Forecast 2018-2026 illuminated by new report ...
The latest market report published by Credence Research, Inc. “In-Vitro Diagnostics Quality Control Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global in-vitro diagnostics quality control market was valued at US$ 854.0 Mn in 2017 and expected to grow at compound an
Research Subscription Model- KBV Research ...
All about Subscription Model A subscription model is based on the idea of selling a product or service to obtain monthly or yearly subscription revenue. The model primarily focuses upon customer retention rather than customer acquisition. Essentially, subscription models pay attention to the way
Ein Spin Off aus einem internationalen Konzern erfolgreich umgesetzt ...
Dank unserer erfahrenen Spezialisten im Beraterteam konnten wir ein Mandat aus dem Bereich komplexer Anlagenbau erhalten. Die Aufgabenstellung war ungewöhnlich und lautete: die Fertigung aus einem zugekauften Unternehmen auszugliedern und zu verkaufen. Hier galt es zunächst in der Analyse di
Erfolgreiche Unternehmensübergabe zweier Unternehmen ...
Auch wenn Meldungen über Geschäftsschließungen an der Tagesordnung sind, so gibt es doch auch immer wieder positive Meldungen über den Erhalt und die Fortführung von Unternehmen. Wie in diesem Fall, als es der UnternehmensBörse Grönig & Kollegen gelang, die Unternehmensnachfolge für glei
